Bank of New York Mellon’s American Renal Associates Holdings, Inc ARA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q1 | – | Sell |
-58,132
| Closed | -$665K | – | 4403 |
|
|
2020
Q4 | $665K | Sell |
58,132
-4,186
| -7% | -$47.7K | ﹤0.01% | 3473 |
|
|
2020
Q3 | $429K | Sell |
62,318
-7,878
| -11% | -$51.7K | ﹤0.01% | 3565 |
|
|
2020
Q2 | $458K | Buy |
70,196
+164
| +0.2% | +$1.06K | ﹤0.01% | 3528 |
|
|
2020
Q1 | $463K | Sell |
70,032
-192
| -0.3% | -$1.67K | ﹤0.01% | 3410 |
|
|
2019
Q4 | $728K | Sell |
70,224
-1,276
| -2% | -$10.9K | ﹤0.01% | 3388 |
|
|
2019
Q3 | $452K | Sell |
71,500
-2,720
| -4% | -$20.3K | ﹤0.01% | 3588 |
|
|
2019
Q2 | $552K | Buy |
74,220
+19,232
| +35% | +$127K | ﹤0.01% | 3552 |
|
|
2019
Q1 | $338K | Buy |
54,988
+2,074
| +4% | +$24K | ﹤0.01% | 3704 |
|
|
2018
Q4 | $609K | Sell |
52,914
-3,184
| -6% | -$54.3K | ﹤0.01% | 3382 |
|
|
2018
Q3 | $1.22M | Buy |
56,098
+3,365
| +6% | +$63.7K | ﹤0.01% | 3151 |
|
|
2018
Q2 | $831K | Buy |
52,733
+5,478
| +12% | +$86.1K | ﹤0.01% | 3349 |
|
|
2018
Q1 | $891K | Sell |
47,255
-507
| -1% | -$10K | ﹤0.01% | 3282 |
|
|
2017
Q4 | $831K | Buy |
47,762
+6,536
| +16% | +$90.2K | ﹤0.01% | 3354 |
|
|
2017
Q3 | $617K | Sell |
41,226
-62
| -0.2% | -$974 | ﹤0.01% | 3478 |
|
|
2017
Q2 | $766K | Buy |
41,288
+4,874
| +13% | +$84.7K | ﹤0.01% | 3405 |
|
|
2017
Q1 | $614K | Sell |
36,414
-1,518
| -4% | -$30.3K | ﹤0.01% | 3473 |
|
|
2016
Q4 | $807K | Buy |
37,932
+14,408
| +61% | +$296K | ﹤0.01% | 3372 |
|
|
2016
Q3 | $430K | Buy |
23,524
+3,971
| +20% | +$89.5K | ﹤0.01% | 3609 |
|
|
2016
Q2 | $567K | Buy |
+19,553
| New | +$544K | ﹤0.01% | 3464 |
|
Bank of New York Mellon's ARA Position: Q1 2021 in Review
Bank of New York Mellon sold out of American Renal Associates Holdings, Inc (ARA) in Q1 2021, closing a stake of 58,132 shares — an estimated $665K sold.
Bank of New York Mellon first reported a position in ARA in Q2 2016 and held it in 19 quarters. The position peaked at $1.22M in Q3 2018. 0 funds tracked by Wall St. Rank hold ARA as of Q1 2021.
- Bank of New York Mellon reported no remaining American Renal Associates Holdings, Inc position as of Q1 2021 after selling out during the quarter.
- Bank of New York Mellon sold 58,132 American Renal Associates Holdings, Inc shares in Q1 2021, an estimated $665K.
- Bank of New York Mellon first reported a position in American Renal Associates Holdings, Inc in Q2 2016 and held it in 19 quarters.
- Bank of New York Mellon's American Renal Associates Holdings, Inc position peaked at $1.22M in Q3 2018.
- 0 funds tracked by Wall St. Rank held American Renal Associates Holdings, Inc as of Q1 2021.
Based on Bank of New York Mellon's 13F filing for Q1 2021, filed 13 May 2021.